Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-23

Clinical Trial Update: The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Replenix Power of Three With Resveratrol for acne vulgaris; study is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Replenix Power of Three With Resveratrol

Snippet

Sponsor: Yardley Dermatology Associates | Conditions: Acne Vulgaris | Phase 4 | Status: TERMINATED